70 related articles for article (PubMed ID: 15872045)
1. Antisense phosphorodiamidate morpholino oligomer inhibits viability of Escherichia coli in pure culture and in mouse peritonitis.
Geller BL; Deere J; Tilley L; Iversen PL
J Antimicrob Chemother; 2005 Jun; 55(6):983-8. PubMed ID: 15872045
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of gene expression in Escherichia coli by antisense phosphorodiamidate morpholino oligomers.
Geller BL; Deere JD; Stein DA; Kroeker AD; Moulton HM; Iversen PL
Antimicrob Agents Chemother; 2003 Oct; 47(10):3233-9. PubMed ID: 14506035
[TBL] [Abstract][Full Text] [Related]
3. Bacterial resistance to antisense peptide phosphorodiamidate morpholino oligomers.
Puckett SE; Reese KA; Mitev GM; Mullen V; Johnson RC; Pomraning KR; Mellbye BL; Tilley LD; Iversen PL; Freitag M; Geller BL
Antimicrob Agents Chemother; 2012 Dec; 56(12):6147-53. PubMed ID: 22985881
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomers.
Ge Q; Pastey M; Kobasa D; Puthavathana P; Lupfer C; Bestwick RK; Iversen PL; Chen J; Stein DA
Antimicrob Agents Chemother; 2006 Nov; 50(11):3724-33. PubMed ID: 16966399
[TBL] [Abstract][Full Text] [Related]
5. Understanding Antisense Oligonucleotide Efficiency in Inhibiting Prokaryotic Gene Expression.
Story S; Bhaduri S; Ganguly S; Dakarapu R; Wicks SL; Bhadra J; Kwange S; Arya DP
ACS Infect Dis; 2024 Mar; 10(3):971-987. PubMed ID: 38385613
[TBL] [Abstract][Full Text] [Related]
6. Machine Learning To Predict Cell-Penetrating Peptides for Antisense Delivery.
Wolfe JM; Fadzen CM; Choo ZN; Holden RL; Yao M; Hanson GJ; Pentelute BL
ACS Cent Sci; 2018 Apr; 4(4):512-520. PubMed ID: 29721534
[TBL] [Abstract][Full Text] [Related]
7. An Amphipathic trans-Acting Phosphorothioate DNA Element Delivers Uncharged PNA and PMO Nucleic Acid Sequences in Mammalian Cells.
Jain HV; Beaucage SL
Curr Protoc Nucleic Acid Chem; 2016 Mar; 64(1):4.69.1-4.69.22. PubMed ID: 27516815
[TBL] [Abstract][Full Text] [Related]
8. Gene-specific effects of antisense phosphorodiamidate morpholino oligomer-peptide conjugates on Escherichia coli and Salmonella enterica serovar typhimurium in pure culture and in tissue culture.
Tilley LD; Hine OS; Kellogg JA; Hassinger JN; Weller DD; Iversen PL; Geller BL
Antimicrob Agents Chemother; 2006 Aug; 50(8):2789-96. PubMed ID: 16870773
[TBL] [Abstract][Full Text] [Related]
9. A comparative analysis of peptide-delivered antisense antibiotics using diverse nucleotide mimics.
Ghosh C; Popella L; Dhamodharan V; Jung J; Dietzsch J; Barquist L; Höbartner C; Vogel J
RNA; 2024 May; 30(6):624-643. PubMed ID: 38413166
[TBL] [Abstract][Full Text] [Related]
10. Sequence specificity defines the effectiveness of PPMOs targeting
Nanayakkara AK; Moustafa DA; Pifer R; Goldberg JB; Greenberg DE
Antimicrob Agents Chemother; 2023 Sep; 67(9):e0024523. PubMed ID: 37610213
[TBL] [Abstract][Full Text] [Related]
11. Pseudomonas aeruginosa Antivirulence Strategies: Targeting the Type III Secretion System.
Goldberg JB; Crisan CV; Luu JM
Adv Exp Med Biol; 2022; 1386():257-280. PubMed ID: 36258075
[TBL] [Abstract][Full Text] [Related]
12. RNA: packaged and protected by VLPs.
Fang PY; Bowman JC; Gómez Ramos LM; Hsiao C; Williams LD
RSC Adv; 2018 Jun; 8(38):21399-21406. PubMed ID: 35539947
[TBL] [Abstract][Full Text] [Related]
13. Scaffold size-dependent effect on the enhanced uptake of antibiotics and other compounds by Escherichia coli and Pseudomonas aeruginosa.
Yamamoto K; Yamamoto N; Ayukawa S; Yasutake Y; Ishiya K; Nakashima N
Sci Rep; 2022 Apr; 12(1):5609. PubMed ID: 35379875
[TBL] [Abstract][Full Text] [Related]
14. Bacterial Nosocomial Infections: Multidrug Resistance as a Trigger for the Development of Novel Antimicrobials.
Sousa SA; Feliciano JR; Pita T; Soeiro CF; Mendes BL; Alves LG; Leitão JH
Antibiotics (Basel); 2021 Aug; 10(8):. PubMed ID: 34438992
[TBL] [Abstract][Full Text] [Related]
15. Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Retain Activity against Multidrug-Resistant Pseudomonas aeruginosa
Moustafa DA; Wu AW; Zamora D; Daly SM; Sturge CR; Pybus C; Geller BL; Goldberg JB; Greenberg DE
mBio; 2021 Jan; 12(1):. PubMed ID: 33436433
[TBL] [Abstract][Full Text] [Related]
16. Cardiolipin-Based Lipopolyplex Platform for the Delivery of Diverse Nucleic Acids into Gram-Negative Bacteria.
Perche F; Le Gall T; Montier T; Pichon C; Malinge JM
Pharmaceuticals (Basel); 2019 May; 12(2):. PubMed ID: 31141930
[TBL] [Abstract][Full Text] [Related]
17. Anti-Sense Antibiotic Agents as Treatment for Bacterial Infections.
Stewart DB
Surg Infect (Larchmt); 2018; 19(8):831-835. PubMed ID: 30256744
[No Abstract] [Full Text] [Related]
18. Macromolecular Conjugate and Biological Carrier Approaches for the Targeted Delivery of Antibiotics.
Tram NDT; Ee PLR
Antibiotics (Basel); 2017 Jul; 6(3):. PubMed ID: 28677631
[TBL] [Abstract][Full Text] [Related]
19. Fighting against evolution of antibiotic resistance by utilizing evolvable antimicrobial drugs.
Cansizoglu MF; Toprak E
Curr Genet; 2017 Dec; 63(6):973-976. PubMed ID: 28497241
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
